Enzymatica AB (publ) (STO:ENZY)
1.850
+0.025 (1.37%)
Feb 10, 2026, 5:15 PM CET
Enzymatica AB Employees
Enzymatica AB had 21 employees as of September 30, 2025. The number of employees increased by 4 or 23.53% compared to the same quarter last year.
Employees
21
Change
4
Growth
23.53%
Revenue / Employee
2.51M SEK
Profits / Employee
-2.58M SEK
Market Cap
449.06M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 21 | 4 | 23.53% |
| Jun 30, 2025 | 21 | 5 | 31.25% |
| Mar 31, 2025 | 21 | 5 | 31.25% |
| Dec 31, 2024 | 21 | 3 | 16.67% |
| Sep 30, 2024 | 17 | -2 | -10.53% |
| Jun 30, 2024 | 16 | -5 | -23.81% |
| Mar 31, 2024 | 16 | -6 | -27.27% |
| Dec 31, 2023 | 18 | -3 | -14.29% |
| Sep 30, 2023 | 19 | -4 | -17.39% |
| Jun 30, 2023 | 21 | -2 | -8.70% |
| Mar 31, 2023 | 22 | -2 | -8.33% |
| Dec 31, 2022 | 21 | -5 | -19.23% |
| Sep 30, 2022 | 23 | -4 | -14.81% |
| Jun 30, 2022 | 23 | -1 | -4.17% |
| Mar 31, 2022 | 24 | 0 | - |
| Dec 31, 2021 | 26 | 6 | 30.00% |
| Sep 30, 2021 | 27 | 9 | 50.00% |
| Jun 30, 2021 | 24 | 5 | 26.32% |
| Mar 31, 2021 | 24 | 7 | 41.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Orexo AB | 104 |
| EQL Pharma AB | 22 |
| Cinclus Pharma Holding AB | 19 |
| Nanexa AB | 15 |
| Cereno Scientific AB | 10 |
| Newbury Pharmaceuticals AB | 8 |
| Moberg Pharma AB | 6 |
| Enorama Pharma AB | 5 |